Melodiol Global Health Ltd

Melodiol Global Health (ASX:ME1) is a global pharmaceutical company developing a portfolio of cannabis-derived therapeutic, nutraceutical, & lifestyle products.

[Melodiol Global Health Ltd @MelodiolGlobal]

📰@StockheadAU Top ASX Health Stocks: #Cannabis play Melodiol Global Health (ASX:ME1) has released its Q2 CY24 results including unaudited revenue of $4.8m, a 9% increase on Q1 CY24

#ME1 #potstocks #ASX #ASXnews
https://t.co/VT6n5ucbrM

[Melodiol Global Health Ltd @MelodiolGlobal]

ICYMI: Melodiol Q2 Revenue and Updates
⬆️ Q2 2024 unaudited revenues total $4.8m, a 9% increase on Q1 2024 ($4.4m)
⬆️ Brings H1 2024 unaudited revenues to $9.2m, a 31% increase on H1 2023 ($7.0m)
More: https://t.co/PEjjrpvWnS #ME1 #potstocks #ASX

[Melodiol Global Health Ltd @MelodiolGlobal]

📰@StockheadAU Top ASX Health Stocks: #Cannabis play Melodiol Global Health (ASX:ME1) has released its Q2 CY24 results including unaudited revenue of $4.8m, a 9% increase on Q1 CY24

#ME1 #potstocks #ASX #ASXnews
https://t.co/VT6n5ucJhk

[Melodiol Global Health Ltd @MelodiolGlobal]

Melodiol Q2 Revenue and Updates
⬆️ Q2 2024 unaudited revenues total $4.8m, a 9% increase on Q1 2024 ($4.4m)
⬆️ Brings H1 2024 unaudited revenues to $9.2m, a 31% increase on H1 2023 ($7.0m)
More: https://t.co/PEjjrpvWnS #ME1 #potstocks #ASX

[Melodiol Global Health Ltd @MelodiolGlobal]

ICYMI: #Mernova Q2 Revenue and Updates
-Q2 2024 unaudited confirmed purchase orders total $2.0m (C$1.8m), a 25% increase on Q1 2024 ($1.6m), and a 33% increase on Q2 2023 ($1.5m)
-Significant number of new product launches and provincial approvals
https://t.co/VIiwkQfCmX #ME1

[Melodiol Global Health Ltd @MelodiolGlobal]

#Mernova Q2 Revenue and Updates
-Q2 2024 unaudited confirmed purchase orders total $2.0m (C$1.8m), a 25% increase on Q1 2024 ($1.6m), and a 33% increase on Q2 2023 ($1.5m)
-Significant number of new product launches and provincial approvals
More: https://t.co/VIiwkQgacv #ME1

[Melodiol Global Health Ltd @MelodiolGlobal]

CEO and Managing Director, Mr William Lay commented on Melodiol Global Health's corporate update:

https://t.co/35wspdGhIP #ME1 #potstocks #ASX #ASXnews

[Melodiol Global Health Ltd @MelodiolGlobal]

ICYMI: Corporate Update
-Two independent appraisals received for Mernova land and building, with values ranging from $10.4 million to $12.0 million (C$9.5 million to C$11.0 million)
More: https://t.co/yETj5Slkwn #ME1 #potstocks #ASX #ASXnews

[Melodiol Global Health Ltd @MelodiolGlobal]

📰@StockheadAU: Melodiol Global Health says its Canadian subsidiary Mernova will use strong valuations of its land and building to attempt to simplify and improve the cannabis company’s balance sheet.

#ME1 #potstocks #ASX #ASXnews
https://t.co/Y3ZTBoTM5A

[Melodiol Global Health Ltd @MelodiolGlobal]

CEO and Managing Director, Mr William Lay commented on Melodiol Global Health's corporate update:

https://t.co/35wspdGPyn #ME1 #potstocks #ASX #ASXnews

[Melodiol Global Health Ltd @MelodiolGlobal]

ICYMI: Corporate Update
-Two independent appraisals received for Mernova land and building, with values ranging from $10.4 million to $12.0 million (C$9.5 million to C$11.0 million)
More: https://t.co/yETj5SlSlV #ME1 #potstocks #ASX #ASXnews

[Melodiol Global Health Ltd @MelodiolGlobal]

ICYMI: Mernova’s Strong Progress Continues
-Agreements made with contract growers to supplement existing capacity given strong demand
-Q2 confirmed purchase orders of $1.56m to date, highlighting ongoing strength of Ritual brand

More: https://t.co/hnQkGFQtxB #ME1 #potstocks #ASX

[Melodiol Global Health Ltd @MelodiolGlobal]

Mernova’s Strong Progress Continues
-Agreements made with contract growers to supplement existing capacity given strong demand
-Q2 confirmed purchase orders of $1.56m to date, highlighting ongoing strength of Ritual brand

More: https://t.co/hnQkGFQtxB #ME1 #potstocks #ASX

[Melodiol Global Health Ltd @MelodiolGlobal]

ICYMI: Mernova’s Strong Progress Continues
-Additional product launches across various provinces in addition to those previously announced
-Q2 confirmed purchase orders of $1.3m to date
More: https://t.co/K031lc4Gme #ME1 #Mernova #potstocks

[Melodiol Global Health Ltd @MelodiolGlobal]

📰@StockheadAU ASX Health Stocks: Melodiol Global Health (ASX:ME1) says its wholly owned Canadian subsidiary, Mernova, continues to make strong operational progress in Q2.

More: https://t.co/iOWWPjyRdU #ME1 #potstocks #ASXnews

[Melodiol Global Health Ltd @MelodiolGlobal]

Mernova’s Strong Progress Continues
-Additional product launches across various provinces in addition to those previously announced
-Q2 confirmed purchase orders of $1.3m to date
More: https://t.co/K031lc5ebM #ME1 #Mernova #potstocks

[Melodiol Global Health Ltd @MelodiolGlobal]

ICYMI: Quarterly Activities Report: Melodiol delivers $4.4m in revenue during Q1 FY24 – a 91% increase the PCP

https://t.co/I7w5fXDvgH #ME1 #potstocks #ASX

[Melodiol Global Health Ltd @MelodiolGlobal]

Quarterly Activities Report: Melodiol delivers $4.4m in revenue during Q1 FY24 – a 91% increase the PCP

https://t.co/I7w5fXE36f #ME1 #potstocks #ASX

[Melodiol Global Health Ltd @MelodiolGlobal]

ICYMI📰@StockheadAU: Melodiol Global Health has generated $4.1 million in unaudited revenues for Q1 FY24, a 79% increase on the prior corresponding period, providing what it says is a ‘strong foundation for the remainder of FY24’.

#potstocks #ME1 #ASXnews
https://t.co/C1EcymZLtz

[Melodiol Global Health Ltd @MelodiolGlobal]

📰@StockheadAU: Melodiol Global Health has generated $4.1 million in unaudited revenues for Q1 FY24, a 79% increase on the prior corresponding period, providing what it says is a ‘strong foundation for the remainder of FY24’.

#potstocks #ME1 #ASXnews
https://t.co/C1Ecyn0jj7